BRGX
Bioregenx, Inc.
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern. As reflected in the accompanying financial statements, for the three months ended March 31, 2026, the Company incurred a net loss of $(26,415), generated cash from operations of $26,629 and had a stockholder’s deficit of $4,533,316 as of that date. At March 31, 2026, the Company had cash on hand in the amount of $45,806. In addition, notes payable of $522,500 are in default. As a result, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Company with tickers: BRGX
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2025-12-31 | 9,956 | 65,956 | -56,000 | 1.00 |
| 2025-12-15 | 65,956 | 0 | +65,956 | 1.00 |
| 2025-10-15 | 5,579 | 161,579 | -156,000 | 1.00 |
| 2025-09-30 | 161,579 | 0 | +161,579 | 1.00 |
| 2025-06-30 | 10,681 | 10,681 | 0 | 1.00 |
Showing 1–5 of 5 settlements